Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biological markers as classifiers for depression: a multivariate study

L Staner1, P Linkowski, J Mendlewicz

  • 1Dept of Psychiatry, Erasme Hospital, Free University of Brussels, Belgium.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study.

Acta psychiatrica Scandinavica·2018
Same author

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.

Pharmacological reviews·2018
Same author

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder.

Acta psychiatrica Scandinavica·2018
Same author

Genetics of bipolar disorders.

Acta neuropsychiatrica·2016
Same author

Molecular genetic findings in mood disorders.

Acta neuropsychiatrica·2016
Same author

New molecular genetic findings in the genetics of affective disorders.

Acta neuropsychiatrica·2016

Depression is biologically heterogeneous, with distinct patient subgroups identified by hormonal and sleep markers. Understanding these differences is crucial for accurate diagnosis and targeted research in mood disorders.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Psychiatry

Background:

  • Depression is a complex mood disorder with diverse clinical presentations.
  • Biological markers, including hypothalamic-pituitary-adrenal (HPA) axis activity and thyroid-stimulating hormone (TSH) response, are investigated for diagnostic and prognostic value.
  • Previous studies suggest potential biological heterogeneity in depression, but clear subgroup identification remains challenging.

Purpose of the Study:

  • To investigate biological heterogeneity in a non-selected group of depressed patients using a combination of neuroendocrine and sleep measures.
  • To identify distinct subgroups of depression based on biological variables through principal component and cluster analysis.
  • To explore the clinical characteristics associated with identified biological subgroups.

Related Experiment Videos

Main Methods:

  • Seventy-four non-selected depressed patients underwent assessment of delta TSH, REM latency, and post-dexamethasone cortisol levels.
  • Principal component analysis (PCA) was performed on biological variables (Delta TSH, REM latency, cortisol, basal TSH) along with demographic data (gender, age).
  • Cluster analysis was applied to the principal component scores to identify patient subgroups.

Main Results:

  • A three-cluster solution was identified, with distinct subgroups characterized by different biological profiles.
  • Cluster I (n=29) exhibited HPA hyperactivity, severe depression, endogenous features, and anxiety.
  • Cluster III (n=10) consisted exclusively of females with increased TSH response to TRH, displaying sadness and older age.
  • Cluster II (n=35) showed the least HPA axis disturbance, reversed sex ratio, less severe depression, and greater mood reactivity.

Conclusions:

  • The study demonstrates significant biological heterogeneity within the depressive illness.
  • Distinct subgroups of depression can be identified based on neuroendocrine and sleep parameters.
  • Future research on biological markers in depression must account for patient age, gender, and illness severity to ensure robust findings.